Although it has been noted that PGE2 was involved in suppressing NK-cell and B-cell activation and proliferation (21, 26, 27), neither the COX-2 nor mPGES-1 inhibitor was sufficient to recruit these cells to the tumor site in this study, indicating the insufficient stimulation of appropriate chemokines by these drugs. This evidence concerns the gene PTGS2 and neoplasm.